2026-05-20T04:01:37Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/236262024-11-28T17:21:28Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16960col_20.500.12105_16961col_20.500.12105_16962col_20.500.12105_16967col_20.500.12105_16978

00925njm 22002777a 4500 dc Moreau, Philippe author Chari, Ajai author Oriol, Albert author Martinez-Lopez, Joaquin author Haenel, Mathias author Touzeau, Cyrille author Ailawadhi, Sikander author Besemer, Britta author de la Rubia Comos, Javier author Encinas, Cristina author Mateos, Maria-Victoria author Salwender, Hans author Rodriguez-Otero, Paula author Hulin, Cyrille author Karlin, Lionel author Sureda, Anna author Bargay Lleonart, Joan author Benboubker, Lotfi author Rosiñol, Laura author Tarantolo, Stefano author Terebelo, Howard author Yang, Shiyi author Wang, Jing Jing author Nnane, Ivo author Qi, Ming author Kosh, Michele author Delioukina, Maria author Goldschmidt, Hartmut author Moreau, Philippe author Chari, Ajai author Oriol, Albert author Martinez-Lopez, Joaquin author Haenel, Mathias author Touzeau, Cyrille author Ailawadhi, Sikander author Besemer, Britta author de la Rubia Comos, Javier author Encinas, Cristina author Mateos, Maria-Victoria author Salwender, Hans author Rodriguez-Otero, Paula author Hulin, Cyrille author Karlin, Lionel author Sureda, Anna author Bargay Lleonart, Joan author Benboubker, Lotfi author Rosiñol, Laura author Tarantolo, Stefano author Terebelo, Howard author Yang, Shiyi author Wang, Jing Jing author Nnane, Ivo author Qi, Ming author Kosh, Michele author Delioukina, Maria author Goldschmidt, Hartmut author 2023-03-07 Moreau P, Chari A, Oriol A, Martinez-Lopez J, Haenel M, Touzeau C, et al. Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood Cancer J. 2023 Mar 7;13(1):33. 10.1038/s41408-023-00805-x 2044-5385 Blood cancer journal https://hdl.handle.net/20.500.13003/18923 36882409 L2021978120 2-s2.0-85149595607 https://hdl.handle.net/20.500.12105/23626 950825100001 Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS